|
|
|
Abilify - Clozaril - Geodon - Risperdal - Seroquel - Zyprexa Attorneys
Philadelphia, Pennsylvania, New Jersey, Delaware
800-597-9585
|
Prescribed
to treat illnesses ranging from anxiety to schizophrenia, Zyprexa and other atypical antipsychotic medications have been associated with reported cases of
diabetes among users. The most severe cases have resulted in
coma or death.
Eli Lilly, maker of Zyprexa, announced in 2005 that it had agreed to settle an estimated 8,000 lawsuits and that it would establish a fund of up to $690 million to settle claims. (See the news release about the settlement.)
It was more recently alleged, in a December 2006 New York Times article, that Eli Lilly "engaged in a decade-ling effort to play down the risks of Zyprexa" by keeping important information from doctors about the drug's links to obesity and diabetes. (See article.)
In an unrelated side effect, the U.S. Food and Drug Administration had previously issued a Public Health Advisory noting that using atypical antipsychotics to treat behavioral disorders in elderly patients with dementia was associated with increased mortality due in most cases to heart failure or infections.
The FDA advisory pertained to Zyprexa; Abilify, made by Bristol-Myers Squibb; Risperdal, Janssen; Seroquel, AstraZeneca; Clozaril, Novartis; and Geodon, Pfizer. (See the FDA news release.)
If you or someone you know took Zyprexa, Abilify, Clozaril, Risperdal, Seroquel or Geodon and suffered diabetes, other illness or death you may want to contact a Zyprexa attorney.
The FDA in September 2003 required that manufacturers add a warning statement on labels noting that hyperglycemia or elevated blood sugar levels have been reported in patients while taking atypical antipsychotic medications.
Zyprexa, introduced in 1996, is the largest-selling drug among the class of antipsychotics, with more than 17 million people worldwide having used Zyprexa. The drug was first approved for use in the United
States for the treatment of schizophrenia, a mental
illness in which patients suffer hallucinations, delusions and
withdrawal. Four years later Zyprexa was approved for short-term
treatment of acute manic episodes associated with bipolar disorder.
In some cases, hyperglycemia has reportedly resolved
when the medication was discontinued, but some patients had to continue
with anti-diabetic treatment even after they stopped taking
the antipsychotic medication.
Kline & Specter P.C. is based in Philadelphia and has some 30 attorneys, several of whom are also highly skilled doctors. Our law firm has had success litigating product liability and prescription drug lawsuits in Pennsylvania, New Jersey and nationwide. For a free evaluation of your case, contact a Zyprexa lawyer today for a free evaluation of your case.
- Using antipsychotic drugs to treat patients with dementia may be fatal, according to researchers here. (Full Story)
Zyprexa and Other Antipsychotic
Medication News
Zyprexa Settlement News Release, June 9, 2005
USA TODAY
Lilly To Pay Nearly $700M To Settle Zyprexa Claims
PRNewswire
Study Demonstrated Long-Term Treatment with Zyprexa Reduced Violent Behavior in People with Schizophrenia Compared to Risperidone
Forbes.com
Zyprexa Issues Are Key Drivers For Eli Lilly
Reuters
Company to warn of possible Risperdal stroke risk
Kline & Specter handles cases in the areas:
In Pennsylvania: Allentown, Altoona, Bethlehem, Doylestown, Erie, Franklin, Gettysburg, Greensburg, Harrisburg, Hershey, Johnstown, Lancaster, Media, Norristown, Pittsburgh, Pottstown, Reading, Scranton, Wilkes-Barre, State College, Sunbury, West Chester, Williamsport, York.
In New Jersey: Atlantic City, Cape May, Cherry Hill, Hackensack, Hoboken, Jersey City, Newark, New Brunswick, Montclair, Newark, New Brunswick, Trenton, Union City, Voorhees.
In Delaware: Dover and Newark regions.
***
Kline & Specter handles major cases throughout the United States. Select a state:
Alabama AL, Alaska AK, Arizona AZ, Arkansas AR, California CA, Colorado CO, Connecticut CT, Delaware DE, District of Columbia DC, Florida FL, Georgia GA, Hawaii HI, Idaho ID, Illinois IL, Indiana IN, Iowa IA, Kansas KS, Kentucky KY, Louisiana LA, Maine ME, Maryland MD, Massachusetts MA, Michigan MI, Minnesota MN, Mississippi MS, Missouri MO, Montana MT, Nebraska NE, Nevada NV, New Hampshire NH, New Jersey NJ, New Mexico NM, New York NY, North Carolina NC, North Dakota ND, Ohio OH, Oklahoma OK, Oregon OR, Pennsylvania PA, Rhode Island RI, South Carolina SC, South Dakota SD, Tennessee TN, Texas TX, Utah UT, Vermont VT, Virginia VA, Washington WA, West Virginia WV, Wisconsin WI, Wyoming WY
Disclaimer: Kline & Specter, P.C. only provides legal advice after having entered into an attorney client relationship, which our website specifically does not create. It is imperative that any action taken be done on advice of counsel. Because every case is different, the description of awards and cases previously handled do not guarantee a similar outcome in current or future cases. The firm practices law in New Jersey as Kline & Specter. Super Lawyers, Best Lawyers in America and other organizations that rate attorneys are not designations that have been approved by the State Supreme Courts or the American Bar Association.
|Home|
|Firm Profile| |Lawyer
Profiles| |Notable Cases|
|In
the News| |On Television| |Contact Us|
Copyright © 2004 Kline & Specter. All rights reserved.
|
|
|
